During the past 25 years, the North Carolina Biotechnology Center has produced many success stories in throughout our state. Below is just a handful of these stories.
 |
Micell's way of coating wire-mesh stents could improve the odds of surviving heart attacks. |
 |
Talecris raised $950 million in American's only biotech Initial Public Offering of the year. |
 |
Vipin Garg, Ph.D., president and CEO of Tranzyme Pharma, exemplifies the best qualities of North Carolina’s extraordinary entrepreneurs. |
 |
Arbovax is working to rid the world of dengue fever, a virus caused by mosquito bites. |
 |
Rachel Roper is researching a unique strategy for stopping the spread of monkeypox, a potentially deadly viral infection. |
 |
Ann-Marie Stomp’s protein production technology using duckweed led to the founding of Pittsboro’s Biolex. |
 |
Embrex provides an in ovo vaccination system that is used around the world. The company was bought by Pfizer in 2007 for $155 million. |
 |
BioResource International manufactures a patented powdered enzyme that helps turn feathers into a digestible and nutritious poultry feed additive. |